LAZARD ASSET MANAGEMENT LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1207017 NEW YORK, NY

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,491,088

-$150,486 QoQ

Shares Held

133,146

-13.9% QoQ

Ownership

0.106%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#90

of 271 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 63% Shared 0% None 37%

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $404,338,249 across 60 Biotechnology names. ARQT ranks #18 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	131,996	$122,461,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	93,287	$46,338,451
3	ONC	BeOne Medicines Ltd.	90,348	$25,746,469
4	REGN	Regeneron Pharmaceuticals, Inc.	36,910	$23,014,861
5	BMRN	Biomarin Pharmaceutical Inc	350,397	$20,049,716
6	EXEL	Exelixis, Inc.	343,029	$18,664,207
7	JAZZ	Jazz Pharmaceuticals plc	69,588	$16,768,620
8	INCY	Incyte Corp	136,684	$15,494,498

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,491,088	133,146	-13.9%	Shares	Sole	2026-08-14
2026-03-31	$3,641,574	154,566	+65.6%	Shares	Sole	2026-05-15
2025-12-31	$2,711,000	93,354	-66.6%	Shares	Sole	2026-02-17
2025-09-30	$5,270,818	279,619	-27.6%	Shares	Sole	2025-11-14
2025-06-30	$5,411,874	386,011	+3.2%	Shares	Sole	2025-08-14
2025-03-31	$5,850,658	374,083	-3.7%	Shares	Sole	2025-05-15
2024-12-31	$5,409,200	388,313	-51.7%	Shares	Sole	2025-02-14
2024-09-30	$7,469,797	803,204	+123.1%	Shares	Sole	2024-11-14
2024-06-30	$3,347,972	359,997	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.